Bruce L. Levine

Center for Cellular Immunotherapies and Department of Pathology and Laboratory Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA

Modeling the Effects of Supply Chain and Operator Disruptions on Cell Therapy Manufacturing Facility Operations During ...
Monday, August 24, 2020
During the COVID-19 pandemic, the delivery of healthcare and the supply chains for critical reagents and supplies needed for the manufacturing both of established and novel therapies have been disrupted. Some critical ... read more